The Marketplace

Universal kinase assays can quickly and effectively screen and triage novel hits.

Discover a better method for consistent TIL isolation and characterization from tumor samples.

Spatial and single cell analyses offer clues to Alzheimer’s disease progression.

Improving cell and gene therapies with single cell sequencing and immune profiling

Explore a collection of studies in drug discovery and development.

Apollo, powered by RedShift BioAnalytics’ proprietary MMS technology, incorporates major advances over first-generation AQS³pro to support rapidly growing market demand.

Scientists incorporate genetic analyses to streamline and accelerate clinical trials

Examining the major differences between Cas9 and Cas12

Discover how capillary-based western blot technology can take protein analysis into the 21st century.

Scientists profiled whole blood samples to find the ideal storage environment for downstream single cell analyses.

ZEISS introduces an integrated solution for multi-modal in situ experiments |  Automated in situ workflows for highly reproducible, precise, and reliable operator-independent data collection | High-throughput data acquisition with high-resolution creating statistically representative results | High-quality data for reliable post-processing, such as strain mapping using digital imaging correlation (DIC), powered by GOM |  Easy data management

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced a range of antibodies that are specific to cemiplimab (Libtayo) and inhibit the binding of the drug to its target, human programmed death receptor-1 (PD-1).

Integrating gold nanoparticles and nanoshells into lateral flow assays

Researchers use ddPCR to monitor quality at each stage of therapy development.

LevitasBio, Inc. today unveiled the LeviCell™  EOS System, their next generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells.

Olympus Corporation (“Olympus”) announced the completion of the separation of its Scientific Solutions business to a wholly-owned subsidiary,  Evident Corporation (“Evident”).

Explore how humanized liver chimeric mouse models smooth the transition between the laboratory and clinical trials.